MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Gender differenes in cognitive functioning in de novo Parkinson’s disease patients

A. Slomp, S. vd Zee, J. Boertien, J. Spikman, T. van Laar (Groningen, Netherlands)

Meeting: MDS Virtual Congress 2020

Abstract Number: 438

Keywords: Cognitive dysfunction, Parkinsonism

Category: Parkinson's Disease: Cognitive functions

Objective: To clarify the differences in cognitive functioning across different cognitive domains, between male and female de novo PD patients.

Background: Parkinson’s disease (PD) is an age-related, progressive neurodegenerative disorder, with cognitive dysfunction as an important non-motor symptom. Research about the cognitive functions of male versus female PD patients is scarce, inconsistent and lacking control groups.

Method: A total of 78 PD patients (67% male) and 67 healthy controls (HC; 54% male) took part in the study. Cognitive functions were assessed using a complete neuropsychological assessment battery covering all cognitive domains. The Movement Disorders Society Unified Parkinson Disease Rating Scale part III (MDS-UPDRS III) was used as a measure of motor performance. Male and female patients and HC were compared at baseline on demographic characteristics and neuropsychological performance.

Results: Male patients showed higher MDS-UPDRS III scores (p = .008) and lower MoCA scores (p < .001) than their female counterparts. Female patients presented with better verbal- and visuospatial memory than male patients (p < .01), the same trend was found in HC. Female patients performed better on attention tasks (p < .0125) and tasks assessing executive functioning (p < .01) than male patients. No significant gender differences were found in the domains of language, social cognition, visuospatial functioning and processing speed, for both patients and HC. Female patients did not differ from female HC on any of the tests conducted, whereas male patients performed significantly worse than male HC on tasks of all domains.

Conclusion: The results of this study add further evidence that gender can influence the clinical presentation of both motor and cognitive symptoms of de novo PD, by more severely affecting male patients. Awareness of these differences could provide insight in underlying pathological mechanisms and facilitate diagnosis and gender-specific clinical treatment.

To cite this abstract in AMA style:

A. Slomp, S. vd Zee, J. Boertien, J. Spikman, T. van Laar. Gender differenes in cognitive functioning in de novo Parkinson’s disease patients [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/gender-differenes-in-cognitive-functioning-in-de-novo-parkinsons-disease-patients/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/gender-differenes-in-cognitive-functioning-in-de-novo-parkinsons-disease-patients/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley